Want to see VSEE full AI Analyst Report?
Top Page
VSee Health
(OTC:VSEE)
Select Model
Select Model
Rating:44Neutral
Price Target:
$2.00
▲(9900.00% Upside)
Action:Reiterated
Date:10/01/26
The score is mainly held back by weak financial performance—declining revenue, very large losses, and sustained negative operating/free cash flow—despite manageable current leverage. Technicals also weigh on the score with the price below key moving averages and a negative MACD. Valuation is only modestly supportive because negative earnings make the P/E difficult to rely on and no dividend yield is available.
Positive Factors
Manageable leverage
The latest balance sheet shows relatively modest debt and moderate leverage, giving VSee Health some financial flexibility compared with a highly indebted business. This can help the company sustain operations and pursue its virtual-care strategy while it works to improve profitability.
Negative Factors
Revenue contraction
Contracting trailing revenue indicates that current demand and business scale are not yet expanding reliably. A shrinking revenue base makes it harder to absorb fixed operating costs, limits investment capacity, and increases the challenge of building a durable path to profitability.
Read all positive and negative factors
Positive Factors
Negative Factors
Manageable leverage
The latest balance sheet shows relatively modest debt and moderate leverage, giving VSee Health some financial flexibility compared with a highly indebted business. This can help the company sustain operations and pursue its virtual-care strategy while it works to improve profitability.
Read all positive factors
VSee Health (VSEE) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$1.55M
Dividend YieldN/A
Average Volume (3M)7.67K
Price to Earnings (P/E)―
Beta (1Y)0.61
Revenue Growth-9.31%
EPS Growth89.42%
CountryUS
Employees209
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)N/A
Shares Outstanding806,078
10 Day Avg. Volume5,295
30 Day Avg. Volume7,665
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.38
Price to Sales (P/S)0.52
P/FCF Ratio-2.17
Enterprise Value/Market Cap5.02
Enterprise Value/Revenue0.62
Enterprise Value/Gross Profit1.63
Enterprise Value/Ebitda-0.86
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
VSee Health Business Overview & Revenue Model
Company Description
VSee Health, Inc. specializes in delivering virtual healthcare solutions. Their flagship offering, iDoc Telehealth, is specifically designed to manage and coordinate comprehensive care for severely ill individuals within various critical care envi...
VSee Health Financial Statement Overview
Summary
Income Statement
23
Negative
Balance Sheet
46
Neutral
Cash Flow
18
Very Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.63M | 14.62M | 10.42M | 5.77M | 6.38M | 7.34M |
| Gross Profit | 4.76M | 7.36M | 7.18M | 3.83M | 4.84M | 5.92M |
| EBITDA | -9.03M | -9.18M | -3.36M | -1.79M | 0.00 | 386.34K |
| Net Income | -13.82M | -14.71M | -57.70M | -3.76M | -836.21K | 475.90K |
Balance Sheet | ||||||
| Total Assets | 16.73M | 22.41M | 19.99M | 805.79K | 2.61M | 117.94M |
| Cash, Cash Equivalents and Short-Term Investments | 454.15K | 5.27M | 326.12K | 118.73K | 230.66K | 760.01K |
| Total Debt | 1.88M | 2.44M | 9.55M | 543.00K | 517.13K | 0.00 |
| Total Liabilities | 9.14M | 16.96M | 20.01M | 5.11M | 2.61M | 4.55M |
| Stockholders Equity | 7.59M | 5.45M | -18.49K | -3.97M | 360.72K | 113.39M |
Cash Flow | ||||||
| Free Cash Flow | -6.32M | -3.48M | -5.84M | -636.93K | -1.45M | -600.11K |
| Operating Cash Flow | -6.31M | -3.45M | -5.79M | -632.60K | -1.45M | -600.11K |
| Investing Cash Flow | -143.21K | -29.93K | -26.14K | -4.33K | 110.12M | -116.73M |
| Financing Cash Flow | 6.83M | 8.42M | 6.02M | 525.00K | -109.32M | 118.09M |
VSee Health Technical Analysis
Neutral
0.02
Price Trends
1.68
Positive
4.44
Negative
12.88
Negative
Market Momentum
>-0.01
Negative
50.09
Neutral
98.21
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For VSEE, the sentiment is Neutral. The current price of 0.02 is below the 20-day moving average (MA) of 1.92, below the 50-day MA of 1.68, and below the 200-day MA of 12.88, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 50.09 is Neutral, neither overbought nor oversold. The STOCH value of 98.21 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for VSEE.
VSee Health Risk Analysis
VSee Health disclosed 62 risk factors in its most recent earnings report. VSee Health reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
VSee Health Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
56 Neutral | $1.59B | -10.15 | -11.63% | ― | -2.38% | 32.73% | |
55 Neutral | $254.79M | -3.14 | -33.27% | ― | -19.00% | 40.98% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
44 Neutral | $1.55M | -0.05 | -400.87% | ― | -9.31% | 89.42% | |
43 Neutral | $4.88M | >-0.01 | -32.44% | ― | -28.30% | -86.74% |
* Healthcare Sector Average
VSEE
VSee Health
1.92
-90.08
-97.91%
TDOC
Teladoc
8.73
>-0.01
-0.11%
ZCMD
Zhongchao
1.10
-1,003.15
-99.89%
AMWL
American Well
14.98
9.83
190.87%
ONMD
OneMedNet
4.37
-17.93
-80.40%
EUDA
EUDA Health Holdings
15.50
-25.50
-62.20%
VSee Health Corporate Events
Private Placements and FinancingRegulatory Filings and Compliance
VSee Health Pursues Private Note and Equity Financing
Neutral
Sep 30, 2026
VSee Health disclosed that it will issue an Additional Vanquish Note, along with shares of common stock issuable upon conversion of the note, in a private transaction exempt from registration under the Securities Act of 1933 and Regulation D. The ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.